• News
  • BioTech

FDA clears two Life Technologies products

Carlsbad-based Life Technologies Inc. (Nasdaq: LIFE) has received clearance from the U.S. Food and Drug Administration for two more diagnostic testing and analysis products.

The FDA gave the company a green light for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits, designed to help determine compatibility between donors and patients for organ and bone marrow transplantation.

The company now plans to submit its Ion Torrent Personal Genome Machine for 510(k) clearance by the FDA, which is needed before marketing new medical devices.


Life Technologies keeps rising on takeover rumor

Regen BioPharma files FDA application for anemia drug

Shire initiates Phase 3 study for patients with rare skin disorders

User Response
0 UserComments

Life Technologies Corp.

Company Website

5791 Van Allen Way
Carlsbad, CA 92008

Life Technologies Corp. Executive(s):

Greg Lucier

  • Chairman, Chief Executive Officer

Related Videos

Effective corporate leadership: Greg Lucier

Nov. 19, 2008 -- Greg Lucier, CEO of Invitrogen Corp., talked to business students at Cal State San Marcos on Nov. 19.

Similar Companies

NAICS - 325414 - Biological Product (except Diagnostic) Manufacturing